鞘氨醇-1-磷酸受体3是拮抗子宫内膜异位症相关纤维化的非激素靶点
病例对照实验室研究及培养子宫内膜异位细胞研究,纳入33名有或无子宫内膜异位症的女性,发现子宫内膜异位病灶腺体S1PR3蛋白表达较对照子宫内膜显著升高且与纤维化程度正相关,S1P通过S1PR3介导上皮-间质转化和纤维化,S1PR3可能成为子宫内膜异位症的新型药理靶点。
要点
- 子宫内膜异位病灶腺体S1PR3表达较对照子宫内膜显著升高,且与纤维化程度正相关。
- S1P通过S1PR3介导上皮子宫内膜异位细胞的上皮-间质转化和纤维化。
- S1PR3下游ezrin和ERK1/2信号参与S1P诱导的上皮-间质转化和纤维化。
核心结论
- 鞘氨醇-1-磷酸受体3可能代表子宫内膜异位症的一种创新药理学靶点。
研究设计与样本
- 病例对照实验室研究及培养子宫内膜异位细胞研究,共纳入33名有或无子宫内膜异位症的女性。
- 子宫内膜异位病灶来自子宫内膜异位症女性(卵巢子宫内膜异位囊肿n=8;深部浸润型子宫内膜异位症n=15,其中泌尿系统n=5、胃肠道n=6、后部n=4),对照子宫内膜来自健康女性n=10,均通过腹腔镜和宫腔镜手术获取。
- 采用免疫组化评估S1PR3表达,Masson三色染色评估纤维化程度,并使用人培养上皮子宫内膜异位12Z细胞评估S1PR3激活的促纤维化机制。
主要发现
- S1PR3蛋白表达水平在子宫内膜异位囊肿和不同定位的深部浸润型子宫内膜异位症腺体部分较对照子宫内膜显著升高,并与纤维化程度正相关。
- S1P在上皮子宫内膜异位细胞中刺激上皮-间质转化和纤维化标志物的表达,对纤维化的发生起关键作用。
- 基因学方法显示S1PR3介导S1P的纤维化效应,S1PR3下游ezrin和细胞外信号调节激酶1和2信号被发现在S1P诱导的上皮-间质转化和纤维化中起关键作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the molecular mechanisms responsible for fibrosis in endometriosis by investigating whether the protein expression levels of sphingosine-1-phosphate receptor 3 (S1PR3), one of the five specific receptors of the bioactive sphingolipid sphingosine-1-phosphate (S1P), correlate with fibrosis extent in endometriotic lesions and which are the cellular mechanisms involved in this process. DESIGN: Case-control laboratory study and cultured endometriotic cells. SETTING: University research institute and university hospital. PATIENT(S): A total of 33 women, with and without endometriosis, were included in the study. INTERVENTIONS(S): Endometriotic lesions were obtained from women with endometriosis (ovarian endometrioma, n = 8; deep infiltrating endometriosis, n = 15; [urological n = 5, gastrointestinal n = 6, and posterior n = 4]) and control endometrium from healthy women, n = 10, by means of laparoscopic and hysteroscopic surgery. The expression of S1PR3 was evaluated using immunohistochemistry and the extent of fibrosis was assessed using Masson's trichrome staining. Human-cultured epithelial endometriotic 12Z cells were used to evaluate the mechanisms involved in the profibrotic effect of S1PR3 activation. MAIN OUTCOME MEASURE(S): The expression of S1PR3 in endometriotic lesions is positively correlated with endometriosis-associated fibrosis. In addition, S1P induced epithelial-mesenchymal transition (EMT) and fibrosis in epithelial endometriotic cells. Using RNA interference and pharmacological approaches, the profibrotic effect of S1P was shown to rely on S1PR3, thus unveiling the molecular mechanism implicated in the profibrotic action of the bioactive sphingolipid. RESULT(S): The protein expression levels of S1PR3 were significantly augmented in the glandular sections of endometrioma and deep infiltrating endometriosis of different localizations with respect to the control endometrium and positively correlated with the extent of fibrosis. Sphingosine-1-phosphate was shown to have a crucial role in the onset of fibrosis in epithelial endometriotic cells, stimulating the expression of EMT and fibrotic markers. Genetic approaches have highlighted that S1PR3 mediates the fibrotic effect of S1P. Downstream of S1PR3, ezrin and extracellular-signal-regulated kinases 1 and 2 signaling were found to be critically implicated in the EMT and fibrosis elicited by S1P. CONCLUSION(S): Sphingosine-1-phosphate receptor 3 may represent a possible innovative pharmacological target for endometriosis.
引用
- Bernacchioni C, Rossi M, Vannuzzi V, et al. Sphingosine-1-phosphate receptor 3 is a non-hormonal target to counteract endometriosis-associated fibrosis. Fertil Steril. 2023. PMID: 38072366. doi:10.1016/j.fertnstert.2023.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。